期刊
DIGESTIVE DISEASES
卷 27, 期 3, 页码 259-268出版社
KARGER
DOI: 10.1159/000228559
关键词
Crohn's disease; Ulcerative colitis; Perinuclear anti-neutrophil antibody; Anti-Saccharomyces cerevisiae antibody; Natural history
Physicians rely heavily on the presence of disease markers to support or even at times modify their clinical impression for certain diseases that can only be diagnosed clinically. Typically these markers play an important role in helping to establish a diagnosis and to evaluate the activity of a chronic disease over time. The diagnosis of inflammatory bowel disease (IBD), however, is not based solely on clinical grounds. Invasive endoscopic and radiological as well as histopathological criteria need to be met in order to make a correct diagnosis and differentiate disease subtypes. The search for novel diagnostic approaches that accurately distinguishes a group of patients with IBD from those unaffected by the disease has become a focus in IBD research. This search, however, has taken a very exciting turn in the direction of finding biologic and genetic markers that can assess the natural history and predict the course of individual's disease including response to treatments over time. Copyright (C) 2009 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据